A case of advanced pancreatic neuroendocrine tumor in which octreotide long-acting repeatable was effective after failure of everolimus and sunitinib

Molecular targeted drugs, such as everolimus and sunitinib, have shown efficacy against advanced pancreatic neuroendocrine tumors. Octreotide, a somatostatin analogue, improves the hormone-related symptoms in patients with neuroendocrine tumors. Furthermore, it has been reported that octreotide has...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int Cancer Conf J
Hlavní autoři: Kitade, Hironori, Ohtsubo, Koushiro, Hokkoku, Kengo, Mori, Mitsue, Osamura, Robert Yoshiyuki, Sakuma, Hiroshi, Nakai, Masuo, Yano, Seiji
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Japan 2018
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6498279/
https://ncbi.nlm.nih.gov/pubmed/31149542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-018-0348-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky